SEATTLE--(BUSINESS WIRE)--Today Cadence BiomedicalTM, maker of Kickstart®, which helps people with neurological conditions recover to walking, announced a new research collaboration with the University of Nebraska Omaha (UNO) to study stroke survivors’ ability to adapt and improve motor skills after using the Kickstart device. Dr. Mukul Mukherjee, assistant professor at UNO and assistant director of the Biomechanics Research Building at UNO, is the principal investigator of this research effort which will incorporate Kickstart into his ground-breaking work with virtual reality and stroke rehabilitation. Cadence co-founder and COO Brian Glaister will consult on the study.
“In our current NIH-funded research, we are identifying ways in which virtual reality environments can create lasting motor adaptations for stroke survivors,” said Dr. Mukherjee. “Kickstart represents a technology that has great potential to enhance such motor adaptations at a relatively low cost. With this collaborative work we hope to enhance gait adaptations that will help to improve therapeutic rehabilitation for stroke survivors. The ultimate objective is to develop low-cost, portable and highly effective therapeutic technology for stroke survivors who do not have access to high-tech therapy centers.”
“We’ve seen the lives of many Kickstart users transform as their walking ability and independence are restored,” said Cadence COO Brian Glaister. “I am extremely excited to be working with Dr. Mukherjee and his team in Biomechanics to further expand the evidence supporting Kickstart’s effectiveness for rehabilitation. The team, facilities and equipment in the Biomechanics Research Building at UNO are second-to-none— we look forward to seeing the results of Dr. Mukherjee’s work and advancing the understanding of Kickstart across the stroke research and clinical communities.”
About Cadence Biomedical
Cadence Biomedical is a commercial-stage medical device company headquartered in Seattle, WA. Cadence manufactures and markets Kickstart®, a neurorehabilitation device designed to accelerate walking recovery in individuals with impairments from stroke, spinal cord injury, multiple sclerosis and other neurological conditions. Kickstart’s unique, patented Exotendon™ technology functions like an artificial tendon to provide stability, support and swing assistance which enables ambulation in the clinic and ultimately into the community.
To learn more about Kickstart and our commitment to equip patients to ‘recover to walking,’ please visit Cadence on the web at www.cadencebiomedical.com.